Concepedia

Mark Manfredi

MM

Statistics

Publications

40

Citations

6.1K

H-Index

28

Active since

1991

Affiliations

Millennium Engineering and Integration (United States)(Current)

Takeda (United States)

Center for Cancer Research

Sarah Cannon

Princeton University

Mark Manfredi is an author at Millennium Engineering and Integration (United States) specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

1991–2022

40

Publications

40

Serine Is an Essential Metabolite for Effector T Cell Expansion

H. Eric, Glenn R. Bantug, Takla Griss et al. · Cell Metabolism · 2017 · 652 citations · Full text

, , +12

Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer

Erik Kupperman, Edmund C. Lee, Yueying Cao et al. · Cancer Research · 2010 · 493 citations

, , +13

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

Luís Felipe Campesato, Sadna Budhu, Jeremy H. Tchaicha et al. · Nature Communications · 2020 · 466 citations · Full text

, , +17

A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment

Marc L. Hyer, Michael A. Milhollen, Jeff Ciavarri et al. · Nature Medicine · 2018 · 456 citations

, , +14

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

Mark Manfredi, Jeffrey Ecsedy, Kristan Meetze et al. · Proceedings of the National Academy of Sciences · 2007 · 413 citations · Full text

, , +14

1–5 of 40